What percentage of head and neck cancers are oropharyngeal?

The two most prevalent tumor sites for patients in the study cohort were the oropharynx (for 32.2% of the patients) and the larynx (31.5%);

How common are oropharyngeal cancers?

According to the American Cancer Society, about 53,000 people in the U.S. develop oropharyngeal cancer each year. This cancer occurs in twice the number of men than women. It occurs in equal amounts in African Americans and Caucasians. The average age at diagnosis is 62.

What is the survival rate for oropharyngeal cancer?

Survival rates for oral and oropharyngeal cancer vary widely depending on the original location and the extent of the disease. In the United States, the overall 5-year survival rate for people with oral or oropharyngeal cancer is 67%. The 5-year survival rate for Black people is 51%, and for White people, it is 69%.

What site in the oropharynx is most common for cancer?

More than 90% of oral and oropharyngeal cancers are squamous cell carcinoma. This means that they begin in the flat, squamous cells found in the lining of the mouth and throat….The most common locations for cancer in the oral cavity are:

  • Tongue.
  • Tonsils.
  • Oropharynx.
  • Gums.
  • Floor of the mouth.

What is the most common site for head and neck tumors?

The oral cavity was the most frequent anatomical site for the head and neck cancers accounting for 37.3 % of patients (Table 1).

Is oropharyngeal cancer curable?

Oral and oropharyngeal cancers can often be cured, especially if the cancer is found at an early stage. Although curing the cancer is the primary goal of treatment, preserving the function of the nearby nerves, organs, and tissues is also very important.

Is oropharyngeal cancer aggressive?

Conclusion. While most HPV-related oropharyngeal cancers display a positive prognosis, it is evident that there is a subset, which behave more aggressively. This early investigation identifies pathologic and radiologic features that may help to predict this behavior.

Is oropharynx cancer curable?